The treatment of chronic kidney failure is a medical success story that Fresenius Medical Care has contributed to substantially.
Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal diseases of which around 3.7 million patients worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
Fresenius Medical Care offers products and services along the entire dialysis value chain from a single source. We care for more than 346,500 patients in our global network of more than 4,000 dialysis clinics. At the same time, we operate 44 production sites on all continents, to provide dialysis products such as dialysis machines, dialyzers and related disposables.
Fresenius Medical Care has more than 125,000 employees in around 50 countries. Our strategy is geared toward sustainable growth. We aim to continuously improve the quality of life of patients with kidney disease by offering innovative products and treatment concepts of the highest quality.
Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and the New York Stock Exchange (FMS).
